Polichem S.A.
Quick facts
Phase 3 pipeline
- amorolfine 5% · Dermatology
Amorolfine is an antifungal agent that inhibits the growth of fungi by interfering with the synthesis of ergosterol, an essential component of fungal cell membranes. - P-3058 · Diabetes
P-3058 is a small molecule that targets the SGLT2 receptor. - P-3058 10% · Diabetes
P-3058 10% is a small molecule that acts as a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2). - P-3073 · Immunology
P-3073 is a small molecule inhibitor of the PI3K delta subunit. - P-3074 · Diabetes
P-3074 is a small molecule that targets the SGLT2 receptor. - P-3074 Vehicle
P-3074 Vehicle is a drug that acts as a vehicle for other pharmaceutical compounds. - vehicle of P-3058 10%
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about Polichem S.A.
What is Polichem S.A.'s pipeline?
Polichem S.A. has 7 drugs in Phase 3, 0 in Phase 2, 1 in Phase 1. Late-stage candidates include amorolfine 5%, P-3058, P-3058 10%, P-3073.
Related
- Sector hub: All tracked pharma companies